Glaxosmithkline Nigeria Rises to Record High as Profit Increases
This article is for subscribers only.
GlaxoSmithKline Consumer Nigeria Plc, a unit of the U.K.’s biggest drugmaker, rose to the highest on record after reporting third-quarter profit increased 13 percent.
The shares gained 4.9 percent to 39.90 naira by the close in Lagos, Nigeria’s commercial capital, the highest since Bloomberg began compiling data on the stock in January 2002. About 192,500 shares changed hands, 32 percent of the three-month daily average, according to data compiled by Bloomberg.